Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

Active Trials Phase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Leukemia, Myeloid, Chronic-Phase

NCT00854841: The Randomized Study of Dasatinib and High-Dose Imatinib (600mg) in Suboptimal Responder

Available

N/A

RoW

Dasatinib and Imatinib, Sprycel and Gliveec

Pusan National University Hospital

Chronic Myeloid Leukemia

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites